对慢性乙肝患者肝细胞癌发展的PAGE-B评分的评估:可靠性,有效性和响应性
Evanthia Tourkochristou1, Maria Kalafateli2, Christos Triantos1
1Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, 26504 Patras, Greece.
Biomedicines
|June 27, 2024
概括
PAGE-B评分准确预测正在接受治疗的慢性乙型肝炎 (CHB) 患者的肝细胞癌 (HCC) 风险. 该模型为监测CHB患者和指导HCC监测策略提供了可靠的工具.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 慢性乙型肝炎 (CHB) 是一个重要的全球健康问题,导致肝病和肝细胞癌 (HCC).
- 为了有效管理CHB,需要对HCC的发展进行勤奋的监测,特别是在接受抗病毒治疗的患者中.
- 现有的HCC风险预后得分可能具有准确性的限制,特别是在接受治疗的CHB患者中.
研究的目的:
- 评估PAGE-B评分在预测CHB患者中HCC发展方面的有效性.
- 与其他风险评分系统相比,评估PAGE-B模型的准确性,有效性和可靠性.
- 为 CHB 患者优化 HCC 监测策略提供见解.
主要方法:
- 关于CHB患者中HCC风险预测现有文献的综述.
- 分析PAGE-B模型的性能,考虑年龄,性别和血小板数.
- 将PAGE-B与HCC监测的替代预后得分进行比较.
主要成果:
- 该PAGE-B模型在预测核酸类比治疗中CHB患者的HCC发生方面表现出高的准确性,有效性和可靠性.
- 与其他风险评分系统相比,PAGE-B显示出优异的预测性能.
- 通过有针对性的调整,有可能进一步提高PAGE-B的预测准确性.
结论:
- PAGE-B评分是准确预测CHB患者HCC发展的可靠工具.
- PAGE-B可以指导在这种高风险人群中对HCC监测的建议.
- 为了改善患者管理,需要对PAGE-B评分进行持续评估和潜在的改进.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...